News

Merck & Co – known as MSD outside the US and Canada – has announced that its respiratory syncytial virus (RSV) preventive ...
Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the European Commission (EC) to treat adults with ...
Results from the study’s open-label period, presented at this year’s European Renal Association Congress, showed that ...
The PM (Pharmaceutical Marketing) Society is delighted to announce a new partnership with the CIM (Chartered Institute of ...
By combining different treatment options – especially those involving immuno-oncology (IO) – researchers aim to develop ...
As the concept of sustainability gains traction in healthcare, it is beginning to influence how value is assessed and ...